James MD - FWBI Old Consultant
Insider
James MD is Consultant of FWBI Old
| Age | 81 |
| Phone | 561 589 7020 |
| Web | https://www.firstwavebio.com |
FWBI Old Management Efficiency
The company has return on total asset (ROA) of (0.2707) % which means that it has lost $0.2707 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1528) %, meaning that it created substantial loss on money invested by shareholders. FWBI Old's management efficiency ratios could be used to measure how well FWBI Old manages its routine affairs as well as how well it operates its assets and liabilities.FWBI Old currently holds 826.84 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. FWBI Old has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about FWBI Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Pablo MD | ZyVersa Therapeutics | N/A | |
| Keith MD | X4 Pharmaceuticals | 54 | |
| Arthur Taveras | X4 Pharmaceuticals | 61 | |
| Dr MedSc | Phio Pharmaceuticals Corp | 68 | |
| Susan Dexter | Sonnet Biotherapeutics Holdings | 70 | |
| Meeshanthini Dogan | Cardio Diagnostics Holdings | 36 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
| James Rolke | Revelation Biosciences | 56 | |
| Timur Dogan | Cardio Diagnostics Holdings | 36 | |
| Manuel Dafonseca | Sonnet Biotherapeutics Holdings | N/A | |
| LaBella MS | ZyVersa Therapeutics | 66 | |
| Renato Skerlj | X4 Pharmaceuticals | N/A | |
| Mary DiBiase | X4 Pharmaceuticals | 64 | |
| Gabriel BA | Immix Biopharma | 38 | |
| MD FACP | Sonnet Biotherapeutics Holdings | 67 | |
| Carol Odle | Revelation Biosciences | N/A | |
| Murray MD | X4 Pharmaceuticals | 63 | |
| Gerald Proehl | Dermata Therapeutics | 66 | |
| MBA MD | Immix Biopharma | 49 | |
| Nandan BS | Immix Biopharma | 63 | |
| DSc MSE | Immix Biopharma | 75 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.27 |
FWBI Old Leadership Team
Elected by the shareholders, the FWBI Old's board of directors comprises two types of representatives: FWBI Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of FWBI. The board's role is to monitor FWBI Old's management team and ensure that shareholders' interests are well served. FWBI Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, FWBI Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James MD, Consultant | ||
| Jack Syage, COO President | ||
| Sarah CPA, Chief Officer | ||
| Amy ChandlerSkerkis, QA Affairs | ||
| RPh MBA, CEO President | ||
| Martin MBA, Senior Development |
FWBI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is FWBI Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | 72.56 M | |||
| Shares Outstanding | 2.03 M | |||
| Shares Owned By Insiders | 5.66 % | |||
| Shares Owned By Institutions | 1.46 % | |||
| Number Of Shares Shorted | 46.6 K | |||
| Price To Book | 1.87 X | |||
| EBITDA | (15.74 M) | |||
| Net Income | (15.79 M) |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in FWBI Stock
If you are still planning to invest in FWBI Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FWBI Old's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |